Title:
ヒトリンパ球由来のワクチンアジュバント
Document Type and Number:
Japanese Patent JP2007531703
Kind Code:
A
Abstract:
The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
Inventors:
Hasumi Kenichiro
Man, Dean Leo
Hanky, kim lauric
Holt, christina michel
Man, Dean Leo
Hanky, kim lauric
Holt, christina michel
Application Number:
JP2006527211A
Publication Date:
November 08, 2007
Filing Date:
February 20, 2004
Export Citation:
Assignee:
HASUMI LLC(DBA SHUKOKAI INTERNATIONAL)
UNIVERSITY OF MARYLAND
UNIVERSITY OF MARYLAND
International Classes:
A61K39/39; A61K6/00; A61K39/00; A61K39/08; A61K39/21; A61K39/29; A61P1/16; A61P31/04; A61P31/18; A61P31/20; A61P37/04; C12Q1/00; A61K
Other References:
JPN6010019413, Ｇ． Ｔ． Ｂｒｉｃｅ, Ｊｏｕｒｎａｌ ｏｆ Ａｃｑｕｉｒｅｄ Ｉｍｍｕｎｅ Ｄｅｆｉｃｉｅｎｃｙ Ｓｙｎｄｒｏｍｅｓ ａｎｄ Ｈｕｍａｎ Ｒｅｔｒｏｖｉｒｏｌｏｇｙ, 1998, Ｖｏｌ．１９， Ｎｏ．３, Ｐａｇｅｓ ２１０−２２０
JPN6010019415, Ｋａｚｕｎｏｒｉ Ｋａｔｏ, Ｊｏｕｒｎａｌ ｏｆ Ｌｅｕｋｏｃｙｔｅ Ｂｉｏｌｏｇｙ, 2001, Ｖｏｌ．７０, Ｐａｇｅｓ ９４１−９４９
JPN6010019415, Ｋａｚｕｎｏｒｉ Ｋａｔｏ, Ｊｏｕｒｎａｌ ｏｆ Ｌｅｕｋｏｃｙｔｅ Ｂｉｏｌｏｇｙ, 2001, Ｖｏｌ．７０, Ｐａｇｅｓ ９４１−９４９
Attorney, Agent or Firm:
Toshiyuki Maruyama
Takao Miyano
Koichi Kitazumi
Toshiya Nagatsuka
Takao Miyano
Koichi Kitazumi
Toshiya Nagatsuka